Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Faeth Therapeutics granted options to purchase an aggregate of 180,350 shares to six new employees as a material inducement to employment under Nasdaq Rule 5635(c)(4). The grants were split between two dates, with 157,850 shares granted on June 25 at an exercise price of $24.67 and 22,500 shares granted on June 29 at an exercise price of $23.22.
Key figures
- Options granted total
- 180350
- Options granted tranche1 price
- 24.67
- Options granted tranche2 price
- 23.22
- Options granted tranche1 shares
- 157850
- Options granted tranche2 shares
- 22500
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.